Clinical analysis of optimized neural network risk models to predict clinically significant prostate cancer and avoid unnecessary prostate biopsies.

Authors

null

Christopher J.D. Wallis

Division of Urology and Surgical Oncology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada

Christopher J.D. Wallis , Robert J Paproski , Desmond Pink , Catalina Vasquez , Adrian S. Fairey , M Eric Hyndman , Armen G. Aprikian , Adam Kinnaird , Perrin Beatty , Christian P. Pavlovich , Leonard S. Marks , John D Lewis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Biologic Correlates

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5023)

DOI

10.1200/JCO.2023.41.16_suppl.5023

Abstract #

5023

Poster Bd #

117

Abstract Disclosures

Similar Posters

First Author: Thorgerdur Palsdottir

First Author: Yifu Shi

Poster

2024 ASCO Genitourinary Cancers Symposium

i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for prostate cancer.

i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for prostate cancer.

First Author: Alexandru George Floares

First Author: Liat Edry-Botzer